Search
for

    Sort by

    Research 211–240 of 702

    1. ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE Al-Azhar Medical Journal · 2023 · 1 citations
    2. Quality of Life in Patients with Alopecia Areata presenting to the Department of Dermatology at a Tertiary Care Hospital of Lahore, Pakistan 2023 · 1 citations
    3. Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study Medical Science · 2022 · 1 citations
    4. New therapies for alopecia areata Bőrgyógyászati és Venerológiai Szemle · 2021 · 1 citations
    5. COMPARISON OF EFFICACY OF VARIOUS TOPICAL TREATMENT MODALITIES IN ALOPECIA AREATA Journal of evolution of medical and dental sciences · 2015 · 1 citations
    6. A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata Journal of health economics and outcomes research · 2026
    7. Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA Dermatology and Therapy · 2026
    8. Metabolic syndrome in Iraqi patients with Alopecia areata: A case control study International Journal of Dermatology Venereology and Leprosy Sciences · 2026
    9. A Comprehensive Systematic Review of the Association Between Vitamin D Deficiency and Alopecia Areata Jurnal Sehat Indonesia (JUSINDO) · 2026
    10. Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia International Journal of Homoeopathic Sciences · 2026
    11. Associated comorbidities in pediatric patients with alopecia areata Boletín Médico Del Hospital Infantil de México (English Edition) · 2026
    12. Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial medRxiv · 2026
    13. Efficacy and safety of tofacitinib in patients with alopecia areata Journal of Pakistan Association of Dermatologists · 2026
    14. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies American Journal of Clinical Dermatology · 2026
    15. Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040 Clinical Cosmetic and Investigational Dermatology · 2026
    16. Alopecia areta: a review International Research Journal of Modernization in Engineering Technology and Science · 2026
    17. Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review 2026
    18. Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study Cureus · 2025
    19. Features of skinfold thickness in Ukrainian men with alopecia areata Reports of Morphology · 2025
    20. Comparative Evaluation of Superficial Cryotherapy vs Intralesional Triamcinolone in Alopecia Areata at a Tertiary Care Center: A Dermoscopic and Clinical Study in Middle-aged Adults The Journal of Medical Sciences · 2025
    21. Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study SKIN The Journal of Cutaneous Medicine · 2025
    22. Characterization of thyroid disorders in alopecia areata patients: A cross-sectional evaluation Journal of Skin and Sexually Transmitted Diseases · 2025
    23. Epidemiology of alopecia areata and its association with atopic dermatitis: A comparative analysis of data from the Moscow Center of Dermatovenereology and Cosmetology and the Federal Registry Meditsinskiy sovet = Medical Council · 2025
    24. Evaluation of Quality of Life, Anxiety and Depression in Patients with Alopecia Areata: A Prospective Case-Control Study Cyprus Journal of Medical Sciences · 2025
    25. Assessment of Serum Level of Brain-Derived Neurotrophic Factor (BDNF) In Pediatric Alopecia Areata: A Case - Control Study 2025
    26. Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast American Journal of Clinical Dermatology · 2025
    27. COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA Pakistan Journal of Intensive Care Medicine · 2025
    28. Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables International Journal of Dermatology Venereology and Leprosy Sciences · 2025
    29. Comparison of Trichoscopic Features of Alopecia Areata before and after Treatment with Intralesional Steroids Pakistan Journal of Health Sciences · 2025
    30. Modern Management Approaches for Alopecia Areata Вопросы современной педиатрии · 2025